AndreaBozzo/ceres-open-data-index huggingface dataset:
Hospice Facilities

<div>[<a href='https://files.hawaii.gov/dbedt/op/gis/data/Hospice_Facilities.pdf' target='_blank' rel='nofollow ugc noopener noreferrer'>Metadata</a>] Locations of hospice facilities in the State of Hawaii as of November 2021. <br /></div><div> Source: Created by Hawaii Statewide GIS Program from data downloaded from Hawaii State Department of Health Office of Health Care Assurance (OHCA). For more information, please see metadata at <a href='https://files.hawaii.gov/dbedt/op/gis/data/Hospice_Facilities.pdf' target='_blank' rel='nofollow ugc noopener noreferrer'>https://files.hawaii.gov/dbedt/op/gis/data/Hospice_Facilities.pdf</a> or contact Hawaii Statewide GIS Program, Office of Planning and Sustainable Development, State of Hawaii; PO Box 2359, Honolulu, Hi. 96804; (808) 587-2846; email: <a href='mailto:gis@hawaii.gov' target='_blank' rel='nofollow ugc noopener noreferrer'>gis@hawaii.gov</a>; Website: <a href='https://planning.hawaii.gov/gis' target='_blank' rel='nofollow ugc noopener noreferrer'>https://planning.hawaii.gov/gis</a>.</div>
Compound 526690: N-Benzylpivalohydrazide

Chemical compound data from PubChem database. IUPAC Name: N-benzyl-2,2-dimethylpropanehydrazide. Molecular Formula: C12H18N2O. Molecular Weight: 206.28. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Ohio (OH)

This report presents estimates for measures of substance use and mental health based on the combined 2010 and 2011 National Surveys on Drug Use and Health (NSDUHs). Topics covered include past month substance use (e.g., illicit drugs, marijuana, cocaine, pain relievers, alcohol, tobacco), substance dependence, abuse, and treatment need, past year serious mental illness (SMI), any mental illness (AMI), suicidal thoughts, and major depressive episode (MDE). Resuts are provided for Ohio for five age groups: 12 to 17, 18 to 25, 26 or older, 18 or older and all persons 12 or older.
Compound 526922: Adamantyl-1-methyl-p-methylphenyl ketone

Chemical compound data from PubChem database. IUPAC Name: 2-(1-adamantyl)-1-(4-methylphenyl)ethanone. Molecular Formula: C19H24O. Molecular Weight: 268.4. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Patent AT-E401551-T1: [Translated] DEVICE FOR DISPLAYING FLIGHT INFORMATION IN AN AIRPLANE

A display system according to various aspects of the present invention provides systems and methods for an integrated graphical user interface which facilitates the interactive and dynamic display aircraft data. In accordance with various aspects of the present invention, a user (e.g., a pilot) provides input to a processor and receives visual feedback via a display produced by one or more monitors. The display includes various graphical elements according to the operator's commands and a predetermined set of rules. By adjusting the information on the display, the user may view the desired information according to the operator's current needs and interests.
Efficacy of ventilation, HEPA air cleaners, universal masking, and physical distancing for reducing exposure to simulated exhaled aerosols in a meeting room-Dataset

There is strong evidence associating the indoor environment with transmission of SARS-CoV-2, the virus that causes COVID-19. SARS-CoV-2 can spread by exposure to droplets and very fine aerosol particles from respiratory fluids that are released by infected persons. Layered mitigation strategies, including but not limited to maintaining physical distancing, adequate ventilation, universal masking, avoiding overcrowding, and vaccination, have shown to be effective in re-ducing the spread of SARS-CoV-2 within the indoor environment. Here, we examine the effect of mitigation strategies on reducing the risk of exposure to simulated respiratory aerosol particles within a classroom-style meeting room. To quantify exposure of uninfected individuals (Recip-ients), surrogate respiratory aerosol particles were generated by a breathing simulator with a headform (Source) that mimicked breath exhalations. Recipients, represented by three breathing simulators with manikin headforms, were placed in a meeting room and affixed with optical particle counters to measure 0.3–3 µm aerosol particles.
Patent AT-E401346-T1: [Translated] ASTHMA SENSITIVITY LOCATION

The present invention describes a susceptibility locus which is functionally related to asthma. The locus maps within human chromosome 7p15-p14. The invention also describes a novel human gene, GPRA. The invention provides diagnostic methods and materials for analysing allelic variation in said locus and the GPRA gene. The invention also provides polypeptides encoded by GPRA gene and antibodies binding to said polypeptides. The invention further provides pharmaceutical compositions for the treatment of asthma, other IgE-mediated disease, chronic obstructive pulmonary disease or cancer.
Systemic and immunotoxicity induced by topical application of perfluorohexane sulfonic acid (PFHxS) in a murine model

Per- and polyfluoroalkyl substances (PFAS) are a large group of stable man-mad surfactants that are incorporated into numerous products for their water and oil resistance and have been associated with adverse health effects.   The present study evaluated the systemic and immunotoxicity of sub-chronic 28- or 10-day dermal exposure of PFHxS (0.625-5% or 15.63-125 mg/kg/dose) in a murine model.  Elevated levels of PFHxS were detected in the serum and urine, suggesting that absorption is occurring through the dermal route.  Liver weight (% body) significantly increased and spleen weight (% body) significantly deceased with PFHxS exposure supported by histopathological changes. Additionally, PFHxS significantly reduced the humoral immune response and altered immune subsets in the spleen, suggesting immunosuppression.  Gene expression changes were observed in the liver, skin, and spleen with genes involved in fatty acid metabolism, necrosis, and inflammation.  Immune-cell phenotyping identified significant decreases in B-cells, NK cells, and CD11b+ cells in the spleen along with increases in CD4+ and CD8+ T-cells, NK cells, and neutrophils in the skin.  These findings support dermal PFHxS-induced liver damage and immune suppression.  These data support PFHxS absorption through the skin and demonstrate immunotoxicity via this exposure route, raising concern about prompting the need for further investigation.
Compound 530059: 5beta-Pregnane-3alpha,17alpha,20alpha-triol, (3,20-O)-diTMSi

Chemical compound data from PubChem database. IUPAC Name: 10,13-dimethyl-3-trimethylsilyloxy-17-(1-trimethylsilyloxyethyl)-1,2,3,4,5,6,7,8,9,11,12,14,15,16-tetradecahydrocyclopenta[a]phenanthren-17-ol. Molecular Formula: C27H52O3Si2. Molecular Weight: 480.9. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Hormone replacement therapy use dramatically increases breast oestrogen receptor expression in obese postmenopausal women

Background
          It is known that use of hormone replacement therapy (HRT) by postmenopausal women increases the risk of breast cancer.
        
        
          Method
          In this study, oestrogen receptor (ER)-α expression is examined using standard immunoperoxidase technique.
        
        
          Results
          Normal breast samples of 11 Australian postmenopausal women have been included in the ER-α study; the result showed a strong correlation (r2 = 0.80) between ER-α expression in normal breast epithelial cells and body mass index (BMI) in normal women who currently use HRT.
        
        
          Conclusion
          This finding confirms that the possibility of increased risk of breast cancer associated with increased ER-α expression in normal breast epithelial cells, in turn associated with high BMI and the use of HRT.
Genetics University of Toronto Thrombophilia Study in Women (GUTTSI): genetic and other risk factors for venous thromboembolism in women

Background
          Women may be at increased risk for venous thromboembolism (VTE) as compared with men. We studied the effects of genetic and biochemical markers of thrombophilia in women, in conjunction with other established risk factors for VTE.
        
        
          Method
          The present retrospective case-control study was conducted in a thrombosis treatment programme at a large Toronto hospital. The cases were 129 women aged 16-79 years with objectively confirmed VTE. Age-matched control individuals were women who were free of venous thrombosis. Neither cases nor control individuals had known cardiovascular disease. Participants were interviewed regarding personal risk factors for VTE, including smoking, history of malignancy, pregnancy, and oestrogen or oral contraceptive use. Blood specimens were analyzed for common single nucleotide polymorphisms of prothrombin, factor V and methylenetetrahydrofolate reductase (MTHFR; C677T, A1298C and T1317C), and the A66G polymorphism for methionine synthase reductase (MTRR).Fasting plasma homocysteine was also analyzed.
        
        
          Results
          Women with VTE were significantly more likely than female control individuals to carry the prothrombin polymorphism and the factor V polymorphism, or to have fasting hyperhomocysteinaemia. Homozygosity for the C677T MTHFR gene was not a significant risk factor for VTE, or were the A1298C or T1317C MTHFR homozygous variants. Also, the A66G MTRR homozygous state did not confer an increased risk for VTE.
        
        
          Conclusion
          Prothrombin and factor V polymorphisms increased the risk for VTE in women, independent from other established risk factors. Although hyperhomocysteinaemia also heightens this risk, common polymorphisms in two genes that are responsible for homocysteine remethylation do not. These findings are consistent with previous studies that included both men and women.
Patent AT-E401528-T1: [Translated] METHOD FOR HEATING AND STORING COLD GASES

Stranded natural gas is sometimes liquefied and sent to other countries that can use the gas in a transport ship. Conventional receiving terminals use large cryogenic storage tanks to hold the liquefied natural gas (LNG) after it has been offloaded from the ship. The present invention eliminates the need for the conventional cryogenic storage tanks and instead uses uncompensated salt caverns to store the product. The present invention can use a special heat exchanger, referred to as a Bishop Process heat exchanger, to warm the LNG prior to storage in the salt caverns or the invention can use conventional vaporizing systems some of which may be reinforced and strengthened to accommodate higher operating pressures. In one embodiment, the LNG is pumped to higher pressures and converted to dense phase natural gas prior to being transferred into the heat exchanger and the uncompensated salt caverns.
Compound 527787: But-2-enyl 2-chlorobenzoate

Chemical compound data from PubChem database. IUPAC Name: but-2-enyl 2-chlorobenzoate. Molecular Formula: C11H11ClO2. Molecular Weight: 210.65. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Weekly COVID-19 Vaccination Coverage among Pregnant Women by Race and Ethnicity

Weekly COVID-19 Vaccination Coverage, Pregnant Women 18-49 Years Old

• COVID-19 vaccination coverage among pregnant women is assessed through the Vaccine Safety Datalink* 

• Data on updated 2023-24 COVID-19 vaccinations among pregnant women was available starting September 23, 2023, and includes doses received starting September 14, 2023.
Compound 529467: Trifluoroacetamide, N-(1-cyclohexylethyl)

Chemical compound data from PubChem database. IUPAC Name: N-(1-cyclohexylethyl)-2,2,2-trifluoroacetamide. Molecular Formula: C10H16F3NO. Molecular Weight: 223.24. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
SHIP Students Entering Kindergarten Ready To Learn 2014-2021

This is historical data. The update frequency has been set to "Static Data" and is here for historic value. Updated on 8/14/2024

Students Entering Kindergarten Ready To Learn - This indicator shows the percentage of students who enter Kindergarten ready to learn. Readiness to learn in the first year of school is strongly linked to later school success, which is predictive of adult health. Full readiness to learn is defined as consistently demonstrating skills, knowledge, and behaviors which are needed to successfully engage in kindergarten curriculum. <a href = "https://health.maryland.gov/pophealth/Documents/SHIP/SHIP%20Lite%20Data%20Details/Student%20Entering%20Kindergarten%20Ready%20to%20Learn.pdf">Link to Data Details </a>
Compound 527841: 2,4-Dichlorobenzyl decyl ether

Chemical compound data from PubChem database. IUPAC Name: 2,4-dichloro-1-(decoxymethyl)benzene. Molecular Formula: C17H26Cl2O. Molecular Weight: 317.3. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Program Instruction (PI-20-11)

This Program Instruction (PI) provides guidance to agencies administering title IV-B, subpart 1 of the Act (the Stephanie Tubbs Jones Child Welfare Services Program) on the supplemental fiscal year (FY) 2020 funding provided under the CARES Act.The PI provides information on the allowable use of the funding and actions states, territories and tribes must take to report on planned and actual use of the funds.

Metadata-only record linking to the original dataset. Open original dataset below.
Compound 529747: 2,2,4,4-Tetramethyl-1,3-cyclobutane-1,3-diol, trans, mono-TBDMS

Chemical compound data from PubChem database. IUPAC Name: 3-[tert-butyl(dimethyl)silyl]oxy-2,2,4,4-tetramethylcyclobutan-1-ol. Molecular Formula: C14H30O2Si. Molecular Weight: 258.47. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Louisiana (LA)

This report presents Louisiana\'s estimates for 25 measures of substance use and mental health based on the combined 2009 and 2010 National Surveys on Drug Use and Health (NSDUHs). Topics covered include past month substance use (e.g., illicit drugs, marijuana, cocaine, pain relievers, alcohol, tobacco), substance dependence, abuse, and treatment need, past year serious mental illness (SMI), any mental illness (AMI), suicidal thoughts, and major depressive episode (MDE). Resuts are provided for Louisiana for five age groups: 12 to 17, 18 to 25, 26 or older, 18 or older and all persons 12 or older.
Compound 525128: 2,3,4-Trimethoxy-6-(methoxymethyl)-5-[3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxyoxane

Chemical compound data from PubChem database. IUPAC Name: 2,3,4-trimethoxy-6-(methoxymethyl)-5-[3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxyoxane. Molecular Formula: C20H38O11. Molecular Weight: 454.5. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 525169: Hexapropylene glycol, monoallyl ether, acetate

Chemical compound data from PubChem database. IUPAC Name: 1-[1-[1-[1-[1-(1-prop-2-enoxypropan-2-yloxy)propan-2-yloxy]propan-2-yloxy]propan-2-yloxy]propan-2-yloxy]propan-2-yl acetate. Molecular Formula: C23H44O8. Molecular Weight: 448.6. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 528348: Phenol, 2,6-dichloro, TMS

Chemical compound data from PubChem database. IUPAC Name: (2,6-dichlorophenoxy)-trimethylsilane. Molecular Formula: C9H12Cl2OSi. Molecular Weight: 235.18. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Mental Health Client-Level Data (MH-CLD) 2021: Data On Clients Receiving Mental Health Treatment Services Through State Mental Health Agencies

This report describes the total number of clients receiving mental health treatment services in 2021 by demographics, National Outcome Measures (NOMs) and the top five mental health diagnoses for children (ages 0 - 17) and adults (18 and older) by geographical distribution. The NOMs presented in this report include stability in housing/residential status, adult employment, and access to services/capacity.
Adoption Excellence Awards

The Adoption Excellence Awards recognize outstanding accomplishments in achieving permanency for America's children waiting in foster care. An annual program that grew out of the Adoption and Safe Families Act of 1997, these awards honor States, local agencies, private organizations, courts, businesses, individuals, and families making key contributions to increasing the number of children from foster care who are adopted or placed in other permanent homes.

To obtain a nomination packet for the 2024 Adoption Excellence Awards, please visit this page
  
  

.

Metadata-only record linking to the original dataset. Open original dataset below.
The enhancement of the hyperglycemic effect of S-nitrosoglutathione and S-nitroso-N-acetylpenicillamine by vitamin C in an animal model

Background
          S-nitrosoglutathione (GSNO) and S-nitroso-N-acetlypenicillamine (SNAP) are two of the most common sources of nitric oxide (NO) in the biomedical field. Vitamin C has been known to accelerate the decomposition of GSNO and SNAP increasing the release and availability of NO which is cytotoxic at non-physiological concentrations. The study investigates any potential detrimental effect of vitamin C and GSNO, vitamin C and SNAP on glucose metabolism in normotensive and normoglycemic dogs.
        
        
          Results
          The results showed that administration of vitamin C (50 mg/kg) and GSNO (35 mg/kg & 50 mg/kg), or vitamin C (50 mg/kg) and SNAP (10 mg/kg) to overnight fasted dogs resulted in significant elevation of the blood glucose levels, attaining maximum level at the 2.0 or 2.5 h time point postprandially. The elevated blood glucose levels were due to significant reduction in plasma insulin levels in the dogs treated with vitamin C and GSNO, or vitamin C and SNAP (P < 0.05). The decreased insulin response was associated with significant elevation of nitric oxide produced from GSNO and SNAP co-administered with vitamin C, as assessed by plasma nitrate/nitrite levels.
        
        
          Conclusions
          The results indicate that enhanced NO release by vitamin C affects postprandial blood glucose and plasma insulin levels and the reduced glucose tolerance is mainly due to impaired insulin release. The clinical relevance of the findings of this study suggest that hypertensive diabetic patients treated with GSNO or SNAP, who are on vitamin C supplements may be more predisposed to further decrease in their glycemic control.
Trend Tables (Prevalence Estimates) - 7.1 to 7.45

These detailed tables show trends in population totals and prevalence estimates of illicit drug use, risk and protective factors, substance initiation, substance dependence/abuse, and need/receipt of substance use treatment from the 2010 National Survey on Drug Use and Health (NSDUH). Substances examined include illicit drugs (e.g., marijuana, cocaine, heroin, hallucinogens (including LSD, PCP, Ecstasy, Ketamine, DMT/AMT/Foxy, Salvia divinorum), inhalants, and the nonmedical use of prescription-type pain relievers (including OxyContin), tranquilizers, stimulants (Adderall) , sedatives (GHB, Ambien), non-prescription cold medicine, alcohol, and tobacco products (including cigarettes, smokeless tobacco, cigars, pipes). Results are provided for lifetime, past year, and past month use by age group, gender, race/ethnicity, education level, employment status, and geographic area. Comparisons are made between 2010 and 2002 through 2009.
Compound 529471: 1,5-Anhydroglucitol, TMS

Chemical compound data from PubChem database. IUPAC Name: trimethyl-[[3,4,5-tris(trimethylsilyloxy)oxan-2-yl]methoxy]silane. Molecular Formula: C18H44O5Si4. Molecular Weight: 452.9. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 530428: Vulgarone B

Chemical compound data from PubChem database. IUPAC Name: 2,6,6,11-tetramethyltricyclo[5.4.0.02,8]undec-10-en-9-one. Molecular Formula: C15H22O. Molecular Weight: 218.33. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
2019 Uniform Reporting System (URS) Table for Federated States of Micronesia

These are the 2019 Uniform Reporting System (URS) Output Tables for Federated States of Micronesia. The URS state reporting system is collected annually to support the Community Mental Health Services Block Grant program. State Mental Health Authorities report on National Outcome Measures (NOMS), evidence-based practices, and utilization measures providing an overview of state mental health delivery systems.
Comparative transcription map of the

Background
          To support the positional cloning of the mouse mutation wobbler (wr) the corresponding regions on human Chr2p13-14 and mouse Chr11 were analyzed in detail and compared with respect to gene content, order, and orientation.
        
        
          Results
          The gene content of the investigated regions was highly conserved between the two species: 20 orthologous genes were identified on our BAC/YAC contig comprising 4.5 Mb between REL/Rel and RAB1A/Rab1a. Exceptions were pseudogenes ELP and PX19 whose mouse counterparts were not located within the analyzed region. Two independently isolated genomic clones indicate an inversion between man and mouse with the inverted segment being identical to the wobbler critical interval. We investigated the wobbler critical region by extensive STS/EST mapping and genomic sequencing. Additionally, the full-length cDNA sequences of four newly mapped genes as well as the previously mapped gene Otx1 were established and subjected to mutation analysis. Our data indicate that all genes in the wr critical region have been identified.
        
        
          Conclusion
          Unexpectedly, neither mutation analysis of cDNAs nor levels of mRNAs indicated which of the candidate genes might be affected by the wr mutation. The possibility arises that there might be hitherto unknown effects of mutations, in addition to structural changes of the mRNA or regulatory abnormalities.
Compound 527627: Hexanoic acid, 2-ethyl-2-methyl, methyl ester

Chemical compound data from PubChem database. IUPAC Name: methyl 2-ethyl-2-methylhexanoate. Molecular Formula: C10H20O2. Molecular Weight: 172.26. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.